Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Novartis Vaccines & Diagnostics Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (3)
Australian Public Assessment Report (AusPAR) (1)

Date

2015 (1)
2014 (3)

Results for "[search-keyword]"

Search

Sponsor content

4 result(s) found, displaying 1 to 4

AusPAR: Inactivated influenza virus vaccine (containing 15 μg haemagglutinin of virus Types A H1N1+ A H3N2 + B)

24 August 2015

Australian Public Assessment Report (AusPAR)
Novartis Vaccines & Diagnostics Pty Ltd - PROCLEIX ULTRIO Assay - In-Vitro Diagnostics, Non-Sterile Cancelled under s41GL(d)

27 August 2014

Cancellation by sponsor

Requested by Novartis Vaccines & Diagnostics Pty Ltd
Novartis Vaccines & Diagnostics Pty Ltd - PROCLEIX ULTRIO Plus Assay Cancelled under s41GL(d)

27 August 2014

Cancellation by sponsor

Requested by Novartis Vaccines & Diagnostics Pty Ltd
Novartis Vaccines & Diagnostics Pty Ltd - Procleix Ultrio Assay - HIV1/Hepatitis C virus/Hepatitis B virus nucleic acid IVD, kit, nucleic acid technique (NAT) Cancelled under s41GL(d)

27 August 2014

Cancellation by sponsor

Requested by Novartis Vaccines & Diagnostics Pty Ltd

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.

Novartis Vaccines & Diagnostics Pty Ltd

Type

Date

AusPAR: Inactivated influenza virus vaccine (containing 15 μg haemagglutinin of virus Types A H1N1+ A H3N2 + B)

Novartis Vaccines & Diagnostics Pty Ltd - PROCLEIX ULTRIO Assay - In-Vitro Diagnostics, Non-Sterile Cancelled under s41GL(d)

Novartis Vaccines & Diagnostics Pty Ltd - PROCLEIX ULTRIO Plus Assay Cancelled under s41GL(d)

Novartis Vaccines & Diagnostics Pty Ltd - Procleix Ultrio Assay - HIV1/Hepatitis C virus/Hepatitis B virus nucleic acid IVD, kit, nucleic acid technique (NAT) Cancelled under s41GL(d)

Help us improve the Therapeutic Goods Administration site